obsolete_common variable immunodeficiency: ['A hypogammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells. Patients with common variable immunodeficiency have marked reduction in serum levels of both immunoglobulin G (IgG) and immunoglobulin A (IgA); about half of these patients also have reduced immunoglobulin M (IgM).', 'A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.', 'Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.']
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D3_CVID_BCELL
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
89 |
4. Check minimum number of eventsNone |
89 |
5. Include endpointsNone |
89 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D83
- Name in latin
- Deficientia immunalis variabilis communis praecipue cum abnormalitatibus numeri et functionis cellularum B
Similar endpoints
↥List of similar endpoints to
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
based on the number of shared cases.
Similar with more cases:
- Common variable immunodeficiency
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 312 | 164 | 146 |
| Only index persons | 287 | 154 | 133 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 49.79 | 49.97 | 49.50 |
| Only index persons | 47.93 | 48.90 | 46.80 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 52 | 35 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 46.84 | 47.90 | 45.27 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 89
- Matched controls
- 890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
128.2
89
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
74.9
61
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
69.0
57
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
53.7
46
*
ZX120
NOMESCO Finland
Intravenous
18.4
41.5
43
43
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
47.4
30.8
37
13
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
27.5
25
*
C01CA24
ATC
epinephrine; parenteral
14.1
27.5
30
31
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
11.2
26.9
37
53
J47
ICD-10 Finland
Bronchiectasis
127.0
26.4
27
*
J01MA12
ATC
levofloxacin; systemic
9.3
25.1
45
88
6BA02, ,
NOMESCO Finland
+∞
24.0
22
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
22.9
21
*
J01MA14
ATC
moxifloxacin; systemic
9.6
21.7
32
49
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
20.6
19
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.3
19.6
43
101
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
19.5
18
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.9
18.9
50
140
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.1
18.3
31
55
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
9.3
17.0
24
34
UGC12
NOMESCO Finland
Flexible bronchoscopy
19.9
16.6
25
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.4
16.0
62
236
Z3231
NOMESCO Finland
Registered nurse
5.9
15.9
48
147
TDM10
NOMESCO Finland
Puncture of maxillary antrum
15.5
15.6
26
23
WW200
NOMESCO Finland
Immunization
31.7
15.5
20
8
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
69.1
15.4
17
*
J01FA15
ATC
telithromycin; oral
8.1
15.1
24
39
H02AB07
ATC
prednisone; oral
6.8
14.5
28
56
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
20.7
14.3
21
13
Z01.8
ICD-10 Finland
Other specified special examinations
5.6
14.1
39
109
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.0
13.7
25
47
Z2221
NOMESCO Finland
Medical doctor
5.1
13.2
47
161
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
12.8
12
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
12.8
12
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
15.7
12.4
20
16
TPH04
NOMESCO Finland
Cathetrisation of vein
5.0
12.4
39
120
SPAT1262
SPAT
Handing over of treatment supplies
5.6
12.3
30
74
J01FF01
ATC
clindamycin; systemic
4.8
12.0
43
146
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
75.1
11.9
13
*
H02AB06
ATC
prednisolone; systemic
5.1
11.9
63
288
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
10.7
11.7
23
28
UJF30
NOMESCO Finland
Ileoscopy through colon
6.3
11.2
22
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
22.2
10.7
15
8
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
124.0
10.7
11
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
10.6
10
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
9.1
10.3
22
31
R50.9
ICD-10 Finland
Fever, unspecified
5.0
10.1
27
71
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.1
10.0
47
190
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
10.7
9.9
19
22
M05BA04
ATC
alendronic acid; oral
11.6
9.8
18
19
TGC00
NOMESCO Finland
Bronchial lavation
20.4
9.8
14
8
J01FA06
ATC
roxithromycin; oral
4.1
9.6
56
261
JN4BD
NOMESCO Finland
Extensive body CT
6.1
9.6
19
38
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.0
9.5
44
175
Z3226
NOMESCO Finland
Physiotherapist
4.6
9.3
28
81
J01MA02
ATC
ciprofloxacin; systemic
3.9
9.2
49
214
GD1AD
NOMESCO Finland
Thorax CT examination
12.6
8.7
15
14
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
8.5
8
*
J01FA09
ATC
clarithromycin; systemic
3.6
8.3
47
210
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
10.0
8.2
16
19
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.5
8.1
19
31
XW000
NOMESCO Finland
Bone marrow biopsy
20.6
7.8
11
6
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
15.2
7.6
12
9
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
87.0
7.5
8
*
UJF92
NOMESCO Finland
Capsular endoscopy
17.7
7.4
11
7
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
7.4
7
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
7.4
7
*
132
Kela drug reimbursment
Sarcoidosis
+∞
7.4
7
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
7.4
7
*
C03CA01
ATC
furosemide; systemic
3.7
7.3
30
107
J32.4
ICD-10 Finland
Chronic pansinusitis
22.2
7.3
10
5
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
7.3
34
132
ZXD10
NOMESCO Finland
Scheduled procedure
3.3
7.2
45
210
R01AD09
ATC
mometasone; nasal
3.4
7.0
60
336
ZXE00
NOMESCO Finland
One hour or less
3.2
7.0
48
236
A07AA02
ATC
nystatin; oral
9.0
6.9
14
18
J45.9
ICD-10 Finland
Asthma, unspecified
3.8
6.8
26
88
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.3
6.6
17
32
A02BC01
ATC
omeprazole; systemic
3.2
6.4
35
149
H02AB04
ATC
methylprednisolone; systemic
4.0
6.3
21
64
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
6.3
6
*
D73.1
ICD-10 Finland
Hypersplenism
+∞
6.3
6
*
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
6.3
6
*
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
6.3
6
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.4
6.2
28
105
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
40
0
+∞
45.85
3.2
0.0
18.30
—
u/l
—
40
0
70
157
17.20
37.19
5.7
1.4
0.80
2.24
g/l
10.90
35
111
30
48
8.92
19.45
2.0
1.2
132.41
613.97
u/ml
0.46
18
43
29
49
8.30
17.82
2.4
1.3
—
—
—
0
0
19
7
33.88
15.01
1.3
1.4
507.53
586.00
e6/l
—
19
7
22
15
19.01
14.52
2.7
2.2
—
—
—
0
0
22
16
17.81
14.18
1.6
1.1
—
—
—
0
0
16
5
38.41
13.08
1.8
1.6
—
—
—
0
0
35
97
5.30
12.62
2.9
1.5
—
—
—
0
0
30
77
5.37
11.73
3.7
1.9
2.47
2.47
g/l
0.01
30
71
11
0
+∞
11.71
1.8
0.0
1.02
—
mg/l
—
5
0
11
0
+∞
11.71
1.8
0.0
0.30
—
mg/l
—
6
0
11
0
+∞
11.71
1.8
0.0
0.15
—
mg/l
—
6
0
11
0
+∞
11.71
1.8
0.0
1.58
—
mg/l
—
5
0
11
0
+∞
11.71
1.8
0.0
0.69
—
mg/l
—
6
0
11
0
+∞
11.71
1.8
0.0
0.14
—
mg/l
—
5
0
11
0
+∞
11.71
1.8
0.0
0.39
—
mg/l
—
5
0
11
0
+∞
11.71
1.8
0.0
2.15
—
mg/l
—
6
0
11
0
+∞
11.71
1.8
0.0
0.23
—
mg/l
—
5
0
11
0
+∞
11.71
1.8
0.0
0.15
—
mg/l
—
5
0
29
73
5.41
11.58
2.6
1.4
—
—
—
0
0
17
11
18.74
11.37
1.6
1.5
—
—
—
0
0
61
309
4.10
9.14
8.8
8.7
1.21
1.22
mmol/l
0.56
53
269
27
78
4.53
8.95
2.8
1.4
—
—
—
0
0
18
37
5.84
8.80
2.2
1.2
—
—
—
0
0
13
9
16.64
8.50
1.6
1.2
—
—
—
0
0
18
27
8.07
8.10
3.3
1.4
—
—
—
0
0
11
6
20.62
7.82
1.3
1.5
—
—
—
0
0
19
50
4.56
6.96
4.4
2.6
5.67
5.80
kpa
0.20
19
50
12
13
10.46
6.52
1.8
1.2
—
—
—
0
0
6
0
+∞
6.32
1.7
0.0
—
—
—
0
0
12
14
9.70
6.28
1.8
1.1
—
—
—
0
0
9
7
14.10
5.71
1.7
1.3
—
—
—
0
0
39
190
2.87
5.47
4.4
2.6
0.22
0.36
e6/l
0.38
32
142
9
8
12.33
5.42
1.7
1.1
—
—
—
0
0
9
8
12.33
5.42
1.7
1.1
—
—
—
0
0
44
238
2.68
4.94
4.8
3.0
—
—
—
0
0
8
7
12.39
4.88
1.5
1.1
—
—
—
0
0
8
7
12.39
4.88
1.1
1.7
—
—
—
0
0
8
7
12.39
4.88
2.6
1.0
—
—
—
0
0
8
7
12.39
4.88
2.6
1.0
—
—
—
0
0
15
43
3.99
4.86
3.4
2.3
4.27
4.57
kpa
0.25
15
43
7
5
15.01
4.65
1.6
1.2
—
—
—
0
0
8
8
10.83
4.62
3.8
3.1
—
—
—
0
0
8
8
10.83
4.62
2.0
1.1
—
—
—
0
0
13
29
5.06
4.46
1.3
1.1
—
—
—
0
0
20
74
3.20
4.45
9.3
8.8
104.15
104.15
mmol/l
0.00
20
74
8
9
9.62
4.37
1.6
1.1
—
—
—
0
0
10
17
6.48
4.27
2.0
2.1
—
—
—
0
0
12
26
5.16
4.24
2.7
1.5
—
—
—
0
0
8
10
8.65
4.15
2.0
1.1
—
—
—
0
0
83
683
4.19
3.90
50.4
14.3
14.91
14.45
%
0.43
83
676
8
12
7.20
3.76
1.3
1.6
—
—
—
0
0
30
151
2.49
3.73
3.2
2.1
—
—
—
0
0
10
21
5.22
3.68
5.9
2.8
23.80
24.99
mmol/l
—
10
21
38
215
2.34
3.64
2.7
1.8
85.73
99.72
pmol/l
0.99
26
106
9
17
5.76
3.61
1.7
1.4
—
—
—
0
0
24
110
2.62
3.60
2.9
2.4
0.81
0.77
e6/l
0.05
14
65
12
32
4.17
3.55
9.3
6.2
24.15
25.11
mmol/l
0.28
12
32
6
6
10.59
3.55
1.5
1.2
—
—
—
0
0
6
6
10.59
3.55
1.5
1.2
—
—
—
0
0
50
323
2.25
3.45
3.3
2.6
—
—
—
0
0
45
281
2.22
3.34
10.6
7.2
1.12
1.18
inr
0.38
13
86
23
108
2.52
3.26
3.1
2.5
1.85
2.64
e6/l
0.30
13
63
8
17
5.06
2.99
2.0
1.4
—
—
—
0
0
8
17
5.06
2.99
2.0
1.4
—
—
—
0
0
10
29
3.75
2.79
2.5
2.8
24.74
24.42
mmol/l
—
10
29
7
14
5.33
2.78
3.0
1.2
—
—
—
0
0
5
6
8.73
2.78
5.4
1.3
—
—
—
0
0
5
6
8.73
2.78
5.2
1.3
—
—
—
0
0
16
68
2.65
2.74
7.3
16.9
-1.21
1.31
mmol/l
1.10
11
53
6
10
6.34
2.74
1.2
1.6
—
—
—
0
0
6
11
5.76
2.58
7.8
3.4
47.50
54.64
%
—
6
11
5
7
7.48
2.58
2.0
1.3
—
—
—
0
0
8
21
4.08
2.53
1.8
1.7
—
—
—
0
0
8
22
3.89
2.43
1.9
1.2
—
—
—
0
0
8
23
3.71
2.33
1.9
1.2
—
—
—
0
0
7
18
4.13
2.30
1.3
1.3
—
—
—
0
0
5
9
5.81
2.24
1.2
1.6
—
—
—
0
0
70
564
2.13
2.24
3.4
3.5
—
—
—
0
0
44
308
1.85
2.11
4.5
2.4
106.73
94.23
ug/l
0.19
44
290
49
356
1.84
2.08
5.5
4.7
0.00
0.00
estimate
—
10
63
6
15
4.21
2.07
4.8
1.9
—
—
—
0
0
6
15
4.21
2.07
3.3
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
6
15
4.21
2.07
5.7
2.2
0.26
0.31
u/ml
—
6
8
9
32
3.01
2.07
3.8
2.9
50.27
56.37
%
—
9
32
49
358
1.82
2.02
4.1
3.5
0.00
0.00
estimate
—
9
64
7
21
3.53
2.01
1.1
1.1
—
—
—
0
0
9
33
2.92
1.99
1.3
1.3
—
—
—
0
0
49
360
1.80
1.97
4.5
3.4
0.00
0.00
estimate
—
10
67
8
28
3.04
1.91
2.3
1.9
3.14
1.52
%
—
8
28
7
23
3.21
1.84
1.1
1.2
—
—
—
0
0
8
30
2.83
1.77
1.3
2.0
—
—
—
0
0
28
185
1.75
1.55
3.6
3.7
1.78
10.97
mg/mmol
2.04
18
119
10
46
2.32
1.46
4.6
3.4
1.24
1.23
mmol/l
—
10
40
5
17
3.05
1.38
2.0
1.1
5.80
162.08
e6/l
—
5
12
5
17
3.05
1.38
2.0
1.0
4.20
4.64
e6/l
—
5
11
5
17
3.05
1.38
2.0
1.2
3.26
3.77
mmol/l
—
5
17
9
43
2.21
1.35
1.8
1.3
—
—
—
0
0
8
35
2.41
1.31
12.3
13.3
0.60
0.68
%
—
8
35
5
18
2.88
1.30
2.0
1.3
368.20
397.67
mg/l
—
5
18
8
36
2.34
1.28
12.3
12.2
1.64
1.93
%
—
8
36
6
26
2.40
1.21
1.0
1.2
—
2.30
—
0
6
5
20
2.59
1.16
1.2
1.1
—
7.52
—
0
5
11
60
1.95
1.08
3.0
2.5
—
—
—
0
0
19
126
1.65
1.02
4.3
3.1
17.92
83.17
ng/l
0.73
12
80
19
137
1.49
0.72
1.4
1.3
1.35
6.09
u/ml
—
6
51
5
27
1.90
0.69
2.2
1.7
77.20
95.15
%
—
5
27
22
171
1.38
0.57
2.2
1.7
1.54
0.83
mg/l
0.77
17
133
13
92
1.48
0.54
2.8
2.4
0.62
0.64
ug/l
—
8
46
6
39
1.58
0.54
1.3
2.1
—
4802.67
—
0
12
18
139
1.37
0.48
1.5
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
3.38
—
0
11
23
192
1.27
0.37
5.1
3.7
0.00
0.02
estimate
—
8
60
11
143
0.74
0.35
1.4
2.0
—
—
—
0
0
6
44
1.39
0.35
1.2
1.0
—
—
—
0
0
5
73
0.67
0.27
21.6
6.4
—
—
—
0
0
9
76
1.20
0.25
1.8
2.1
—
—
—
0
0
16
187
0.82
0.23
1.2
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
11
131
0.82
0.18
1.4
1.9
—
—
—
0
0
31
284
1.14
0.18
5.0
3.5
—
—
—
0
0
59
565
1.13
0.17
4.7
3.9
15.07
14.76
pmol/l
0.41
54
523
14
123
1.16
0.13
3.6
3.7
18.12
21.21
%
—
8
45
64
659
0.90
0.12
6.0
5.0
37.36
39.23
mmol/mol
0.54
59
622
5
45
1.12
0.10
1.2
1.3
32.68
25.67
iu/l
—
5
38
5
47
1.07
0.09
1.6
2.6
3.72
4.13
ug/l
—
5
40
5
62
0.80
0.08
3.6
4.5
33.60
32.50
%
—
5
42
7
64
1.10
0.08
1.9
1.8
—
—
—
0
0
11
113
0.97
0.00
2.2
2.0
1.56
1.43
%
0.22
11
104
0
6
0.00
0.00
0.0
1.2
—
7.91
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
9.16
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_CVID_BCELL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_CVID_BCELL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_CVID_BCELL – Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data